Contract Manufacturers Set 100,000 Unit MOQ Floor for HPMC Capsules and 26-Week Softgel Leads

Capacity constraints at major Polish and German contract manufacturers are forcing a structural shift in how European supplement brands manage inventory. Small-batch production is becoming unviable as plants prioritize high-speed runs for tier-one retailers.

Rising MOQs for HPMC and Pullulan Capsules

The standard minimum order quantity for HPMC capsules has shifted from 50,000 to 100,000 units per SKU across most Western European facilities. This change is driven by the 12 percent rise in cleaning and setup labor costs since early 2026. Brands unable to meet these volumes are being pushed toward specialized boutique labs where pricing per 1,000 units is roughly 40 percent higher.

Softgel Backlogs and Material Scarcity

Softgel lead times have reached 26 weeks, primarily due to shortages in high-quality bovine gelatin and the limited number of high-capacity encapsulation machines in the EU. If you are planning a Q1 2027 launch for Omega-3 or Vitamin D3 oil products, you must secure your production slot by mid-September 2026.

• Standard HPMC capsule MOQs now at 100,000 units
• Softgel lead times extended to 26 weeks for new formulations
• Stick pack production queues currently sitting at 18 to 20 weeks
• Setup fees for runs under 50,000 units now exceed 1,500 EUR

Strategic Sourcing Recommendations

Procurement managers should pivot to hard-shell capsules for faster market entry. Transitioning a formula from softgel to liquid-filled hard capsule can reduce lead times by 10 weeks, even if ingredient costs increase by 0.04 EUR per unit. Consolidate your botanical orders to match these new MOQ floors or face significant margin erosion from setup surcharges.